Skip to main content
. 2019 Nov 27;9:17640. doi: 10.1038/s41598-019-54158-2

Figure 5.

Figure 5

Structure-activity analysis of piperidine-pyridoindole and pyrazoloquinoline co-potentiators. (A) Structural determinants of piperidine-pyridoindole (CP-Axxx) and (B) pyrazoloquinoline (CP-Dxxx) co-potentiator activity. (C) Short-circuit current in FRT cells expressing N1303K-CFTR showing responses to 20 µM forskolin (fsk), 5 µM VX-770, and indicated concentrations of CP-A061 (left) and CP-D123 (center). (right) Summary of concentration-dependence data. (D) Short-circuit current in FRT cells expressing Q1313X-CFTR done as in panel C. (right) Summary of concentration-dependence data.